Abstract
Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kessler D. A. Drug promotion and scientific exchange. The role of the clinical investigator. N Engl J Med. 1991 Jul 18;325(3):201–203. doi: 10.1056/NEJM199107183250310. [DOI] [PubMed] [Google Scholar]
- McKinney W. P., Schiedermayer D. L., Lurie N., Simpson D. E., Goodman J. L., Rich E. C. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990 Oct 3;264(13):1693–1697. [PubMed] [Google Scholar]
- Randall T. Ethics of receiving gifts considered. JAMA. 1991 Jan 23;265(4):442–443. doi: 10.1001/jama.265.4.442. [DOI] [PubMed] [Google Scholar]
- Terry P. B. Pulmonary physicians, principles, and pharmaceuticals. Chest. 1991 Jul;100(1):223–226. doi: 10.1378/chest.100.1.223. [DOI] [PubMed] [Google Scholar]
- Williams John R. CMA guidelines on MD-drug industry relations part of international trend. CMAJ. 1992 Feb 1;146(3):386–388. [PMC free article] [PubMed] [Google Scholar]